Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study
Titel:
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study
Auteur:
Mansi, Janine L. Yellowlees, Ann Lipscombe, Julian Earl, Helena M. Cameron, David A. Coleman, Robert E. Perren, Timothy Gallagher, Christopher J. Quigley, Mary Crown, John Jones, Alison L. Highley, Martin Leonard, Robert C. F. Jeffry Evans, T. R.